Related Funds
Fund Name | Location |
Arthurian Life Sciences | England, London, United Kingdom |
Centre for Commercialization of Cancer Immunotherapy | Canada, Montréal, Quebec |
Chengdu Zhengjian | Chengdu, China, Sichuan |
Daishin Securities | Seoul, Seoul-t'ukpyolsi, South Korea |
Daxinli Touzi | Beijing, Beijing, China |
Fairchild Capital Management | China, Hong Kong, Hong Kong Island |
Guorui Investment | China, Jinshan District |
Lovett Miller & Co. | Florida, Jacksonville, United States |
M Krishna Sindhuri Private Trust | - |
Mechanics Bank | California, Richmond, United States |
Mivtach Shamir Holdings LTD | Israel, Tel Aviv, Tel Aviv District |
MTN | Gauteng, Johannesburg, South Africa |
Nextlaw Ventures | California, Palo Alto, United States |
SIP (Strategic Investment Partners Ltd.) | England, London, United Kingdom |
Status.im | Switzerland, Zug, Zug |
Summit Action | New York, New York, United States |
Sunhope Capital | California, San Jose, United States |
Traversant | Arizona, Phoenix, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.